9 METERS BIOPHARMA, INC. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q1 2019 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
9 Meters Biopharma, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q1 2019 to Q1 2023.
  • 9 Meters Biopharma, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending March 31, 2023 was $9.61K, a 61.8% decline year-over-year.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $9.61K -$15.5K -61.8% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $12.9K -$17.2K -57.2% Dec 31, 2022 10-K 2023-03-28
Q3 2022 $16.5K -$18.8K -53.2% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $20.6K -$20.4K -49.7% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $25.2K -$21.9K -46.5% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $30.1K -$23.4K -43.7% Dec 31, 2021 10-K 2022-03-23
Q3 2021 $35.4K -$24.8K -41.2% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $41K +$40.7K +13805% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $47.1K +$46K +4499% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $53.4K +$51.3K +2362% Dec 31, 2020 10-K 2021-03-22
Q3 2020 $60.2K +$56.4K +1515% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $295 -$5.38K -94.8% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $1.02K -$6.99K -87.2% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $2.17K Dec 31, 2019 10-K 2020-03-20
Q3 2019 $3.73K Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $5.68K Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $8.01K Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.